©The Author(s) 2016.
World J Gastroenterol. Dec 7, 2016; 22(45): 9933-9943
Published online Dec 7, 2016. doi: 10.3748/wjg.v22.i45.9933
Published online Dec 7, 2016. doi: 10.3748/wjg.v22.i45.9933
Table 1 Oncogenes and tumor suppressor genes involved in glucose metabolic reprogramming during carcinogenesis
| Genes | Targets | Ref. | |
| Oncogenes | HIF-1 | HK1 | [55] |
| HK2 | [55] | ||
| GAPDH | [55] | ||
| PKM | [55] | ||
| Myc | LDHA | [58] | |
| GLUT1 | [59] | ||
| HK2 | [60] | ||
| CD147 | MCT1 | [62] | |
| GLUT1 | [62] | ||
| PIM1 | GLUT1 | [65] | |
| PKM2 | [65] | ||
| Tumor suppressor | P53 | GLUTs | [66] |
| genes | RRAD | GLUT1 | [67,68] |
| HK2 | [67] |
- Citation: Shang RZ, Qu SB, Wang DS. Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects. World J Gastroenterol 2016; 22(45): 9933-9943
- URL: https://www.wjgnet.com/1007-9327/full/v22/i45/9933.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i45.9933